Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 156,555 | 115,950 | 124,901 | 108,520 | 113,016 |
Receivables | 55,094 | 54,215 | 51,260 | 52,491 | 58,559 |
Inventories | 92,238 | 95,151 | 98,390 | 107,789 | 114,641 |
Other current assets | 1,644 | 1,580 | 2,944 | 2,870 | 10,245 |
TOTAL | $311,918 | $273,368 | $285,083 | $278,087 | $303,167 |
Non-Current Assets | |||||
PPE Net | 352,327 | 358,244 | 359,984 | 368,308 | 382,783 |
Investments And Advances | 651 | 664 | 666 | 730 | 806 |
Intangibles | 579,280 | 583,328 | 577,766 | 576,663 | 577,705 |
Other Non-Current Assets | 138,756 | 142,442 | 136,566 | 134,679 | 134,692 |
TOTAL | $1,071,014 | $1,084,678 | $1,074,982 | $1,080,380 | $1,095,986 |
Total Assets | $1,382,932 | $1,358,046 | $1,360,065 | $1,358,467 | $1,399,153 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 22,255 | 12,297 | 21,670 | 11,817 | 27,783 |
Accounts payable and accrued liabilities | 19,155 | 18,787 | 17,403 | 27,587 | 19,626 |
Accrued Expenses | 60,481 | 54,348 | 61,921 | 69,079 | 76,494 |
TOTAL | $158,569 | $136,876 | $209,154 | $200,242 | $260,882 |
Non-Current Liabilities | |||||
Long Term Debt | 499,332 | 498,691 | 497,999 | 497,713 | 490,501 |
Deferred Revenues | 2,662 | N/A | N/A | N/A | 13 |
aiOther Non-Current Liabilities | 150,549 | 133,489 | 18,691 | 19,367 | 19,022 |
TOTAL | $858,996 | $846,662 | $730,939 | $730,158 | $712,409 |
Total Liabilities | $1,017,565 | $983,538 | $940,093 | $930,400 | $973,291 |
Shareholders' Equity | |||||
Common Shares | 1,705,575 | 1,704,275 | 1,695,565 | 1,689,452 | 1,778,401 |
Retained earnings | -1,346,483 | -1,335,942 | -1,273,618 | -1,265,536 | -1,270,747 |
Other shareholders' equity | -92,947 | -94,758 | -84,798 | -78,776 | -81,792 |
TOTAL | $365,367 | $374,508 | $419,972 | $428,067 | $425,862 |
Total Liabilities And Equity | $1,382,932 | $1,358,046 | $1,360,065 | $1,358,467 | $1,399,153 |